The safety of electroconvulsive therapy in patients with asthma

Paul Mueller, K. M. Schak, R. D. Barnes, K. G. Rasmussen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Patients with depression and other psychiatric disorders being considered for electroconvulsive therapy (ECT) may also have asthma. Since ECT requires the administration of general anaesthesia, it is assumed that extra care should be taken with asthmatic patients before and during ECT. We sought to investigate the safety of ECT in asthmatic patients. Methods: A retrospective review was conducted of the medical records of all of the patients with currently active and managed asthma who underwent ECT for severe depressive syndromes at Mayo Clinic, Rochester, Minnesota, between 1 January 1998, and 30 June 2006. Results: Thirty-four patients with asthma who also underwent ECT were identified. Of these, 27 (79%) were women. The median age was 45 years (range 23-84 years). All 34 patients were using asthma medications daily at the time of ECT. The 34 patients underwent a total of 459 ECT sessions. Four (12%) patients experienced exacerbation of their asthma on a total of five occasions. Each exacerbation was successfully treated with standard asthma medications, and all four patients completed their courses of ECT. Conclusion: ECT in patients with asthma appears to be safe. Although exacerbation of asthma after ECT was rare in our series, a prospective study would be needed to determine the precise risk of pulmonary complications of ECT in asthmatic patients.

Original languageEnglish (US)
Pages (from-to)417-421
Number of pages5
JournalNetherlands Journal of Medicine
Volume64
Issue number11
StatePublished - Dec 2006

Fingerprint

Electroconvulsive Therapy
Asthma
Safety
Depressive Disorder
General Anesthesia
Medical Records
Psychiatry

Keywords

  • Asthma
  • Electroconvulsive therapy
  • Pulmonary complications
  • Reactive airways disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mueller, P., Schak, K. M., Barnes, R. D., & Rasmussen, K. G. (2006). The safety of electroconvulsive therapy in patients with asthma. Netherlands Journal of Medicine, 64(11), 417-421.

The safety of electroconvulsive therapy in patients with asthma. / Mueller, Paul; Schak, K. M.; Barnes, R. D.; Rasmussen, K. G.

In: Netherlands Journal of Medicine, Vol. 64, No. 11, 12.2006, p. 417-421.

Research output: Contribution to journalArticle

Mueller, P, Schak, KM, Barnes, RD & Rasmussen, KG 2006, 'The safety of electroconvulsive therapy in patients with asthma', Netherlands Journal of Medicine, vol. 64, no. 11, pp. 417-421.
Mueller, Paul ; Schak, K. M. ; Barnes, R. D. ; Rasmussen, K. G. / The safety of electroconvulsive therapy in patients with asthma. In: Netherlands Journal of Medicine. 2006 ; Vol. 64, No. 11. pp. 417-421.
@article{4b0884d1f61849d2934b91ba66aa4927,
title = "The safety of electroconvulsive therapy in patients with asthma",
abstract = "Background: Patients with depression and other psychiatric disorders being considered for electroconvulsive therapy (ECT) may also have asthma. Since ECT requires the administration of general anaesthesia, it is assumed that extra care should be taken with asthmatic patients before and during ECT. We sought to investigate the safety of ECT in asthmatic patients. Methods: A retrospective review was conducted of the medical records of all of the patients with currently active and managed asthma who underwent ECT for severe depressive syndromes at Mayo Clinic, Rochester, Minnesota, between 1 January 1998, and 30 June 2006. Results: Thirty-four patients with asthma who also underwent ECT were identified. Of these, 27 (79{\%}) were women. The median age was 45 years (range 23-84 years). All 34 patients were using asthma medications daily at the time of ECT. The 34 patients underwent a total of 459 ECT sessions. Four (12{\%}) patients experienced exacerbation of their asthma on a total of five occasions. Each exacerbation was successfully treated with standard asthma medications, and all four patients completed their courses of ECT. Conclusion: ECT in patients with asthma appears to be safe. Although exacerbation of asthma after ECT was rare in our series, a prospective study would be needed to determine the precise risk of pulmonary complications of ECT in asthmatic patients.",
keywords = "Asthma, Electroconvulsive therapy, Pulmonary complications, Reactive airways disease",
author = "Paul Mueller and Schak, {K. M.} and Barnes, {R. D.} and Rasmussen, {K. G.}",
year = "2006",
month = "12",
language = "English (US)",
volume = "64",
pages = "417--421",
journal = "Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "Van Zuiden Communications BV",
number = "11",

}

TY - JOUR

T1 - The safety of electroconvulsive therapy in patients with asthma

AU - Mueller, Paul

AU - Schak, K. M.

AU - Barnes, R. D.

AU - Rasmussen, K. G.

PY - 2006/12

Y1 - 2006/12

N2 - Background: Patients with depression and other psychiatric disorders being considered for electroconvulsive therapy (ECT) may also have asthma. Since ECT requires the administration of general anaesthesia, it is assumed that extra care should be taken with asthmatic patients before and during ECT. We sought to investigate the safety of ECT in asthmatic patients. Methods: A retrospective review was conducted of the medical records of all of the patients with currently active and managed asthma who underwent ECT for severe depressive syndromes at Mayo Clinic, Rochester, Minnesota, between 1 January 1998, and 30 June 2006. Results: Thirty-four patients with asthma who also underwent ECT were identified. Of these, 27 (79%) were women. The median age was 45 years (range 23-84 years). All 34 patients were using asthma medications daily at the time of ECT. The 34 patients underwent a total of 459 ECT sessions. Four (12%) patients experienced exacerbation of their asthma on a total of five occasions. Each exacerbation was successfully treated with standard asthma medications, and all four patients completed their courses of ECT. Conclusion: ECT in patients with asthma appears to be safe. Although exacerbation of asthma after ECT was rare in our series, a prospective study would be needed to determine the precise risk of pulmonary complications of ECT in asthmatic patients.

AB - Background: Patients with depression and other psychiatric disorders being considered for electroconvulsive therapy (ECT) may also have asthma. Since ECT requires the administration of general anaesthesia, it is assumed that extra care should be taken with asthmatic patients before and during ECT. We sought to investigate the safety of ECT in asthmatic patients. Methods: A retrospective review was conducted of the medical records of all of the patients with currently active and managed asthma who underwent ECT for severe depressive syndromes at Mayo Clinic, Rochester, Minnesota, between 1 January 1998, and 30 June 2006. Results: Thirty-four patients with asthma who also underwent ECT were identified. Of these, 27 (79%) were women. The median age was 45 years (range 23-84 years). All 34 patients were using asthma medications daily at the time of ECT. The 34 patients underwent a total of 459 ECT sessions. Four (12%) patients experienced exacerbation of their asthma on a total of five occasions. Each exacerbation was successfully treated with standard asthma medications, and all four patients completed their courses of ECT. Conclusion: ECT in patients with asthma appears to be safe. Although exacerbation of asthma after ECT was rare in our series, a prospective study would be needed to determine the precise risk of pulmonary complications of ECT in asthmatic patients.

KW - Asthma

KW - Electroconvulsive therapy

KW - Pulmonary complications

KW - Reactive airways disease

UR - http://www.scopus.com/inward/record.url?scp=33845800194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845800194&partnerID=8YFLogxK

M3 - Article

C2 - 17179572

AN - SCOPUS:33845800194

VL - 64

SP - 417

EP - 421

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

SN - 0300-2977

IS - 11

ER -